Arab Journal of Gastroenterology
Volume 11, Issue 2 , Pages 96-100 , June 2010

Irritable bowel syndrome in Upper Egypt: The role of intestinal parasites and evidence of Th2 response

  • Soha Saoud Abdelmoneim

      Affiliations

    • Tropical Medicine and Gastroenterology Department, Faculty of Medicine, Assiut University, Assiut, Egypt
    • Corresponding Author InformationCorresponding author. Tel.: +20 88 2316205.
    • ,
  • Lamia Abdelaziz Galal

      Affiliations

    • Department of Parasitology, Faculty of Medicine, Assiut University, Assiut, Egypt
    • ,
  • Amani Osama

      Affiliations

    • Department of Biochemistry, Faculty of Medicine, Assiut University, Assiut, Egypt
    • ,
  • Nadia Abdel-Salam

      Affiliations

    • Tropical Medicine and Gastroenterology Department, Faculty of Medicine, Assiut University, Assiut, Egypt

Received 7 November 2009 ,Accepted 11 April 2010.

References 

  1. Almy TP, Rothstein RI. Irritable bowel syndrome: classification and pathogenesis. Annu Rev Med. 1987;38:257–265
  2. Schmulson M, Ortiz O, Santiago Lomeli M, et al. Frequency of functional bowel disorders among healthy volunteers in Mexico City. Digest Dis. 2006;24(3–4):342–347
  3. Quigley EM, Locke GR, Mueller Lissner S, et al. Prevalence and management of abdominal cramping and pain: a multinational survey. Aliment Pharmacol Therap. 2006;24(2):411–419
  4. Liebregts T, Adam B, Bredack C, et al. Immune activation in patients with irritable bowel syndrome. Gastroenterology. 2007;132(3):913–920
  5. Sinha P, Ghoshal UC, Choudhuri G, et al. Does Entamoeba histolytica cause irritable bowel syndrome?. Indian J Gastroenterol. 1997;16(4):130–133
  6. Stark D, van Hal S, Marriott D, et al. Irritable bowel syndrome: a review on the role of intestinal protozoa and the importance of their detection and diagnosis. Int J Parasitol. 2007;37(1):11–20
  7. Maizels RM, Bundy DA, Selkirk ME, et al. Immunological modulation and evasion by helminth parasites in human populations. Nature. 1993;365(6449):797–805
  8. Yazdanbakhsh M, van den Biggelaar A, Maizels RM. Th2 responses without atopy: immunoregulation in chronic helminth infections and reduced allergic disease. Trends Immunol. 2001;22(7):372–377
  9. Capron M, Dombrowicz D. Eosinophiles, parasites et allergie: De la biologie à la clinique [Eosinophils, parasites and allergy: from the biological to the clinical]. J Soc Biol. 2002;196(1):23–28
  10. Kristjánsson G, Venge P, Wanders A, et al. Clinical and subclinical intestinal inflammation assessed by the mucosal patch technique: studies of mucosal neutrophil and eosinophil activation in inflammatory bowel diseases and irritable bowel syndrome. Gut. 2004;53(12):1806–1812
  11. Drossman DA, Corazziari E, Talley NJ, et al. Rome II: The functional gastrointestinal disorders. McLean (VA): Degnon Assoc.; 2000;
  12. Ridley DS, Hawgood BC. The value of formol–ether concentration of faecal cysts and ova. J Clin Pathol. 1956;9(1):74–76
  13. Parija SC, Prabhakar PK. Evaluation of lacto-phenol cotton blue for wet mount preparation of feces. J Clin Microbiol. 1995;33(4):1019–1021
  14. Parija SC, Bhattacharya S, Padhan P. Thick stool smear wet mount examination: a new approach in stool microscopy. Trop Doct. 2003;33(3):173
  15. Garcia LS. Diagnostic medical parasitology. 4th ed.. American Society for Microbiology (ASM); 2001;
  16. Benetton ML, Goncalves AV, Meneghini ME, et al. Risk factors for infection by the Entamoeba histolytica/E. dispar complex: an epidemiological study conducted in outpatient clinics in the city of Manaus, Amazon Region, Brazil. Trans Roy Soc Trop Med Hyg. 2005;99(7):532–540
  17. Stark D, Beebe N, Marriott D, et al. Prospective study of the prevalence, genotyping and clinical relevance of Dientamoeba fragilis infections in an Australian population. J Clin Microbiol. 2005;43(6):2718–2723
  18. Savioli L, Smith H, Thompson A. Giardia and Cryptosporidium join the ‘neglected diseases initiative’. Trends Parasitol. 2006;22(5):203–208
  19. Bujanda L, Gutierrez Stampa MA, Caballeros CH, et al. Trastornos gastrointestinales en Guatemala y su relacion con infecciones parasitarias [Gastrointestinal disorders in Guatemala and their relationship with parasitic infections]. Ann Med Interne. 2002;19(1):3–6
  20. Hussain R, Jaferi W, Zuberi S, et al. Significantly increased IgG2 subclass antibody levels to Blastocystis hominis in patients with irritable bowel syndrome. Am J Trop Med Hyg. 1997;56(3):301–306
  21. Stewart GT. Post-dysenteric colitis. Br Med J. 1950;1(4650):405–409
  22. Chaudhary NA, Truelove SC. The irritable colon syndrome; a study of the clinical features, predisposing causes and prognosis in 130 cases. Q J Med. 1962;31:307–322
  23. D’Anchino M, Orlando D, De Feudis L. Giardia lamblia infections become clinically evident by eliciting symptoms of irritable bowel syndrome. J Infect. 2002;45(3):169–172
  24. Tungtrongchitr A, Manatsathit S, Kositchaiwat C, et al. Blastocystis hominis infection in irritable bowel syndrome patients. Southeast Asian J Trop Med Public Health. 2004;35(3):705–710
  25. Anand AC, Reddy PS, Saiprasad GS, et al. Does non-dysenteric intestinal amoebiasis exist?. Lancet. 1997;349(9045):89–92
  26. Sinha P, Naik S, Ayyagari A, et al. Isoenzyme and molecular characterization of Entamoeba histolytica and Entamoeba dispar isolates from symptomatic and asymptomatic subjects. Indian J Gastroenterol. 1999;18(1):18–21
  27. Yakoob J, Jafri W, Jafri N, et al. Irritable bowel syndrome: in search of an etiology: role of Blastocystis hominis. Am J Trop Med Hyg. 2004;70(4):383–385
  28. Babb RR, Wagener S. Blastocystis hominis – a potential intestinal pathogen. West J Med. 1989;151(5):518–519
  29. Dawes RF, Scott SD, Tuck AC. Blastocystis hominis: an unusual cause of diarrhoea. Br J Clin Pract. 1990;44(12):714–716
  30. Doyle PW, Helgason MM, Mathias RG, et al. Epidemiology and pathogenicity of Blastocystis hominis. J Clin Microbiol. 1990;28(1):116–121
  31. Zaki M, Daoud AS, Pugh RN, et al. Clinical report of Blastocystis hominis infection in children. J Trop Med Hyg. 1991;94(2):118–122
  32. Rossignol JF, Kabil SM, Said M, et al. Effect of nitazoxanide in persistent diarrhea and enteritis associated with Blastocystis hominis. Clin Gastroenterol Hepatol. 2005;3(10):987–991
  33. Graczyk TK, Shiff CK, Tamang L, et al. The association of Blastocystis hominis and Endolimax nana with diarrheal stools in Zambian school-age children. Parasitol Res. 2005;98(1):38–43
  34. Grazioli B, Matera G, Laratta C, et al. Giardia lamblia infection in patients with irritable bowel syndrome and dyspepsia: a prospective study. World J Gastroenterol. 2006;12(12):1941–1944
  35. Nanda R, Baveja U, Anand BS. Entamoeba histolytica cyst passers: clinical features and outcome in untreated subjects. Lancet. 1984;2(8398):301–303
  36. Corcoran GD, O’Connell B, Gilleece A, et al. Entamoeba coli as possible cause of diarrhoea. Lancet. 1991;338(8761):254
  37. Wahlgren M. Entamoeba coli as cause of diarrhoea?. Lancet. 1991;337(8742):675
  38. Wilson S, Roberts L, Roalfe A, et al. Prevalence of irritable bowel syndrome: a community survey. Br J Gen Pract. 2004;54(504):495–502
  39. Camilleri M, Carlson P, McKinzie S, et al. Genetic variation in endocannabinoid metabolism, gastrointestinal motility and sensation. Am J Physiol Gastrointest Liver Physiol. 2007;294(1):G13–G19
  40. Armitage E, Drummond HE, Wilson DC, et al. Increasing incidence of both juvenile-onset Crohn’s disease and ulcerative colitis in Scotland. Eur J Gastroenterol Hepatol. 2001;13(12):1439–1447
  41. Gecse K, Róka R, Ferrier L, et al. Increased faecal serine protease activity in diarrhoeic IBS patients: a colonic lumenal factor impairing colonic permeability and sensitivity. Gut. 2008;57(5):591–598
  42. Cenac N, Andrews CN, Holzhausen M, et al. Role for protease activity in visceral pain in irritable bowel syndrome. J Clin Invest. 2007;117(3):636–647
  43. Zuckerman MJ, Watts MT, Ho H, et al. Blastocystis hominis infection and intestinal injury. Am J Med Sci. 1994;308(2):96–101
  44. Van Gool T, Weijts R, Lommerse E, et al. Triple faeces test: an effective tool for detection of intestinal parasites in routine clinical practice. Eur J Clin Microbiol Infect Dis. 2003;22(5):284–290
  45. Ustun S, Turgay N, Delibas SB, et al. Interleukin (IL) 5 levels and eosinophilia in patients with intestinal parasitic diseases. World J Gastroenterol. 2004;10(24):3643–3646

PII: S1687-1979(10)00054-7

doi: 10.1016/j.ajg.2010.04.011

Arab Journal of Gastroenterology
Volume 11, Issue 2 , Pages 96-100 , June 2010

Article Tools

* Image Usage & Resolution